DEEJ(000423)2025-03-20 12:06Group 1: Company Performance Overview - In 2024, the company achieved a revenue of 5.921 billion yuan, a year-on-year increase of 25.57% [2] - Net profit attributable to shareholders reached 1.557 billion yuan, up 35.29% year-on-year [2] - The net profit excluding non-recurring gains and losses was 1.442 billion yuan, reflecting a growth of 33.17% [2] - The net cash flow from operating activities was 2.171 billion yuan, an increase of 11.13% [2] - Basic earnings per share were 2.42 yuan, up 35.20% year-on-year [2] Group 2: Strategic Initiatives - The company focuses on "value reshaping" to maintain its brand position as "the national treasure of nourishment" [2] - A dual-driven growth strategy combining pharmaceuticals and health consumer products is being implemented [3] - The company is enhancing its organizational structure to support high-quality development and talent cultivation [3] Group 3: Product Performance - In 2024, the sales of Ejiao blocks saw double-digit growth [3] - The compound Ejiao syrup experienced a growth rate exceeding 50% [3] - The Taohua Ji brand achieved over 10% growth by expanding its reach [3] - Ejiao powder recorded a growth rate of over 75% through digital marketing efforts [3] Group 4: Future Development Plans - In 2025, the company aims to deepen the integration of the gelatin industry chain and focus on product and service enhancement through digital capabilities [4] - The company plans to strengthen its global supply chain for high-quality raw materials [4] - There is a focus on optimizing product combinations and enhancing digital marketing to improve market competitiveness [5] Group 5: Marketing and Sales Strategies - The company emphasizes consumer-centric strategies and deep collaborations with major retail chains to enhance product quality [6] - The compound Ejiao syrup is positioned for growth in the medical market, which has outpaced retail growth [7] - The Taohua Ji brand will continue to innovate and expand its product matrix in the beauty and health sector [8] Group 6: Investment and Market Expansion - The company is actively seeking acquisition opportunities aligned with its strategic goals in health and beauty sectors [11] - Plans for overseas market expansion have been initiated, focusing on cultural promotion and clinical validation of products [15] - The company maintains a stable pricing strategy based on market supply and demand dynamics [10]